Mr Daniel Getts

CEO at CREATE Medicines

Speaker

Daniel Getts is the CEO and cofounder of CREATE Medicines. Prior to Create Medicines, he was the VP of Research at TCR2 (NASDAQ, TCRR) and a member of the leadership team that successfully guided the company through a series B ($120M) financing and an IPO (~$80M). Dr Getts’s primary duties were to lead the company’s target discovery, preclinical, and translational research programs. These efforts resulted in numerous patent applications, a robust pipeline, and a successfully filed IND.

Before TCR2, Dr. Getts was the primary inventor, founder, and Chief Scientific Officer of Cour Pharmaceuticals Development Company—a nanotechnology platform company focused on autoimmunity and inflammation. Prior to Cour, Dr Getts was the Director of Research & Development at Tolera Therapeutics. Dr. Getts completed his postdoctoral training at Northwestern University in Stephen D. Miller’s laboratory. He holds a PhD in medicine from the University of Sydney and an MBA from Western Michigan University.